Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apply Artificial Intelligence to Determine the Benign or Malignancy for Pulmonary Ground Glass Nodules of Computed Tomography

NCT06282068 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.

NCT NCT06282068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06282068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apply Artificial Intelligence to Determine the Benign or Malignancy for Pulmonary Ground Glass Nodules of Computed Tomography
Lead sponsor
Chung Shan Medical University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2024
Completion date
February 28, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung nodules, early lung cancer, artificial intelligence, chest ct, minimally invasive surgery, lung image analysis software